TrialMolecular & cellular proteomics : MCP2013

Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.

Nilofer Azad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.